But what if you could avoid getting COVID-19 altogether? That’s the potential promise of a new study on a drug made by ...

UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...

In 2020, the Conference on Retroviruses and Opportunistic Infections (CROI) was the first scientific conference to move from ...

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close ...

Providing feedback following point-of-care urine testing for tenofovir concentrations was associated with increased PrEP ...